Treatment of Acromegaly with Obstructive Sleep Apnea or High-Output Heart Failure

Acromegaly can cause progressive soft tissue changes that create substantial operative risk. When severe pharyngeal thickening is present alongside sleep apnea, or when the disease has led to high-output heart failure, perioperative management requires a targeted approach before any surgical intervention.

Clinical Scenario

This protocol addresses patients with acromegaly who present with severe pharyngeal thickening and obstructive sleep apnea, or with high-output heart failure. These comorbidities significantly elevate surgical and anesthetic risk and call for specific preoperative medical management before definitive treatment can proceed safely.

Treatment Approach (Summary)

The recommended approach involves preoperative medical therapy with a somatostatin receptor ligand to reduce surgical risk from these severe comorbidities — the full regimen, including which agent, formulation, and timing, is detailed in the complete protocol.

Reduce soft tissue swelling and improve sleep apnea ahead of surgery
Improve cardiac function in the setting of high-output heart failure

Instant Access to Structured Evidence-Based Regimens

References

For patients with severe pharyngeal thickness and sleep apnea, or high-output heart failure, we suggest medical therapy with SRLs preoperatively to reduce surgical risk from severe comorbidities.
Treatment with SRLs may reduce soft tissue swelling rapidly, with improved sleep apnea and reduced intubation-related complications.
Treatment with SRLs in such patients improves cardiac function and may enhance anesthetic safety, and therefore may be considered in selected patients.

DOI: 10.1210/jc.2014-2700

View source ↗